semaglutide blindness study Nordisk slams linking rare to Ozempic and Wegovy May Be

Wegovy, another weekly injection of semaglutide, is FDA approved for use in patients with obesity, says Minisha Sood, MD, a board-certified endocrinologist at Northwell Healths Lenox Hill Hospital in New York

Pros Natural ingredient profile with clinical backing No prescription required Non-stimulant formula no jitters or crash 180-day money-back guarantee Supports multiple metabolic pathways Positive verified customer reviews Cons Results vary individually not instant Requires consistent daily use for best effect Only available through the official website Higher price point than drugstore supplements May cause mild digestive upset initially Not suitable for pregnant or nursing women Safety guidelines: Always consult your healthcare provider before starting any new supplement, especially if you are taking medication for diabetes, high blood pressure, or any chronic condition

Good luck finding the link

UC Davis exercise physiologist Keith Baar, speaking in late 2025, put it plainly: "It is still important for patients taking GLP-1 medication to limit muscle wasting through exercise and high-quality protein." The American College of Sports Medicine and major endocrinology bodies now recommend that GLP-1 users prioritize: Resistance training with multijoint movements - exercises that load multiple muscle groups simultaneously and create high mechanical tension, particularly in the posterior chain (glutes, hamstrings, lower back) Progressive overload - progressively increasing the demand on the muscles over time to continue signaling retention and growth Consistent training frequency - 3 to 5 sessions per week to maintain the anabolic signal during prolonged caloric restriction Adequate protein intake - 1.2 to 2.0 grams per kilogram of body weight daily, timed around training sessions The challenge for most GLP-1 users is practical: they're often new to structured training, may have limited mobility or joint issues related to their previous weight, and don't want to split their routine across a separate cardio machine and a weights area

Ginsenoside Rg3 exhibits anti-fibrotic effects in both hepatic and cardiac tissues by modulating the TGF-/Smad signaling pathway